Hepatitis B infection among Chinese STD patients in Kuala Lumpur, Malaysia.

This study documents the prevalence of Hepatitis B serological markers among STD patients who have had multiple sexual partners in Kuala Lumpur, Malaysia, and compares the rates with those of a sample of the population with single or no sexual partners. A total of 336 Chinese STD patients (multiple partners group) and 234 Chinese control subjects (non-multiple partner group) were screened. Those with a history of blood transfusion or parenteral drug abuse had been excluded from the study, and all study subjects were heterosexuals. The overall carrier rate was 9.2% for the multiple partner group (MP group) and 6.8% for the non-multiple partner group (NMP group). Infection rates were 64.3% for the MP-group and 38.9% for the NMP group. After adjustments for age and sex, there was no significant difference in carrier rates between the two groups, but infection rates were significantly different with the MP group, being 3.2 times more likely to acquire infection than the NMP group. The study concludes that in heterosexuals, those with multiple sexual partners have increased chances of acquiring HBV infection.
AuthorsC Y Gan, S F Yap, Y F Ngeow, H C Wong
JournalSexually transmitted diseases (Sex Transm Dis) 1991 Apr-Jun Vol. 18 Issue 2 Pg. 84-8 ISSN: 0148-5717 [Print] UNITED STATES
PMID1862464 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Hepatitis B Antibodies
  • Hepatitis B Surface Antigens
  • Hepatitis B e Antigens
  • Adolescent
  • Adult
  • Carrier State (epidemiology)
  • Chi-Square Distribution
  • Female
  • Hepatitis B (complications, epidemiology)
  • Hepatitis B Antibodies (blood)
  • Hepatitis B Surface Antigens (blood)
  • Hepatitis B e Antigens (blood)
  • Humans
  • Malaysia (epidemiology)
  • Male
  • Middle Aged
  • Prevalence
  • Prostitution
  • Sexual Behavior
  • Sexual Partners
  • Sexually Transmitted Diseases (complications)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: